Derosa and colleagues explored the link between fecal Akkermansia muciniphila (Akk) and the clinical benefits of ICIs in patients with NSCLC, finding baseline levels to be predictive of increased response rates and overall survival, irrespective of PD-L1 expression, antibiotics, and performance status (52). This evidence concerns the gene CD274 and non-small cell lung carcinoma.